Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Tristan Knight

13PUBLICATIONS
11CO-AUTHORS
Cardiovascular medicine and haematology not elsewhere classifiedNeurology and neuromuscular diseasesChild and adolescent developmentAdolescent healthInfant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

Sort by Publication Date:
|Nov 06, 2024
Why are Higher CD34+ Cell Doses Associated with Improved Outcomes among Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplant for Central Nervous System Tumors - But Not for High-Risk Neuroblastoma?

Tristan E Knight, Larisa Broglie, Akshay Sharma

|Jan 21, 2022
Malignant Peripheral Nerve Sheath Tumors-A Comprehensive Review of Pathophysiology, Diagnosis, and Multidisciplinary Management.

Samantha W E Knight, Tristan E Knight, Teresa Santiago

|Aug 06, 2021
When it comes to drug access, should children be considered small adults? Countering coverage denials of FLT3 inhibitors in children with FLT3-ITD AML.

Tristan E Knight, Yubin Ge, Jeffrey W Taub

|Jun 15, 2021
Allogeneic hematopoietic stem cell transplantation in an adolescent with Prader-Willi syndrome - unique considerations.

Tristan E Knight, Jane Lowry, Sarah Leppington

|Jan 30, 2020
Clostridium difficile infection in a children's hospital with specific patterns among pediatric oncology and hematopoietic stem cell transplantation populations.

Jessica L Spruit, Tristan Knight, Colleen Sweeney

|Jul 28, 2019
Current Management of Pleuropulmonary Blastoma: A Surgical Perspective.

Samantha Knight, Tristan Knight, Amir Khan

Pageof 3

Frequent Collaborators

2 joint publications

Samantha W E Knight

2 joint publications

Andrew J Murphy

1 joint publications

Donna A Wall

1 joint publications

Jennifer Seelisch

1 joint publications

Jeffrey W Taub

1 joint publications

Johann Hitzler

1 joint publications

Larisa Broglie

1 joint publications

Shoujing Zhao

1 joint publications

Lijing Zhao

1 joint publications

Jessica L Spruit

Frequent Collaborators

2 joint publications

Samantha W E Knight

2 joint publications

Andrew J Murphy

1 joint publications

Donna A Wall

1 joint publications

Jennifer Seelisch

Top Related Videos

Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor (CAR) T Cell Infusions in Mice
05:22

Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor (CAR) T Cell Infusions in Mice

Published on : Feb 24, 2023

2.9K
Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models
08:57

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Published on : May 17, 2024

2.2K
Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors
04:36

Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors

Published on : Oct 17, 2025

76
See more related videos

Top Related Videos

Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor (CAR) T Cell Infusions in Mice
05:22

Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor (CAR) T Cell Infusions in Mice

Published on : Feb 24, 2023

2.9K
Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models
08:57

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Published on : May 17, 2024

2.2K
Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors
04:36

Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors

Published on : Oct 17, 2025

76
See more related videos